Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials
- Citation:
- Ann Oncol vol 21 (2) 312-318
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA032291, CA33601, U10 CA077658, CA32291, CA41287, U10 CA031946, CA77651, U10 CA033601, CA60138, 5P50CA9038, U10 CA077440, CA77440, U10 CA041287, U10 CA047559, U10 CA077651, CA04326, CA47559, CA31946
- Corr. Author:
- Authors:
- M. M. Regan E. K. O'Donnell W. K. Kelly S. Halabi W. Berry S. Urakami N. Kikuno W. K. Oh
- Networks:
- Study
- CALGB-99813
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- carboplatin, estramustine, prostate cancer, taxanes